Deng Huan, Liu Xiangqin, Chen Jie, He Yi, Lin Lanke, Liu Xin, Chen Jiang, Liu Xiaoqi
College of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Department of Laboratory Medicine and Sichuan Provincial Key Laboratory for Human Disease Gene Study, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Front Pharmacol. 2023 Feb 28;14:1126602. doi: 10.3389/fphar.2023.1126602. eCollection 2023.
The highly efficient capture of circulating tumor cells (CTCs) in the blood is essential for the screening, treatment, and assessment of the risk of metastasis or recurrence of cancer. Immobilizing specific antibodies, such as EpCAM antibodies, on the material's surface is currently the primary method for efficiently capturing CTCs. However, the strategies for immobilizing antibodies usually have the disadvantages of requiring multiple chemical reagents and a complex pre-treatment process. Herein we developed a simple strategy for the immobilization of EpCAM antibodies without additional chemical reagents. By utilizing the positive charge property of the photo-functionalized titanium dioxide (TiO), the negatively charged carboxyl terminal of EpCAM antibodies was immobilized by electrostatic interaction, allowing the antibodies to expose the antigen binding site fully. The experimental results showed that the photo-functionalized TiO surface had a marked positive charge and super-hydrophilic properties that could immobilize large amounts of EpCAM antibodies and keep excellent activity. CTCs capture experiments showed that the EpCAM antibodies-modified photo-functionalized TiO could efficiently capture CTCs. The results of blood circulation experiments in rabbits showed that the EpCAM antibodies-modified photo-functionalized TiO could accurately capture CTCs from the whole body's blood. It was foreseen that the strategy of simple immobilization of EpCAM antibodies based on photo-functionalized TiO is expected to serve in the efficient capture of CTCs in the future.
高效捕获血液中的循环肿瘤细胞(CTC)对于癌症转移或复发风险的筛查、治疗及评估至关重要。目前,在材料表面固定特异性抗体(如EpCAM抗体)是高效捕获CTC的主要方法。然而,抗体固定策略通常存在需要多种化学试剂及复杂预处理过程的缺点。在此,我们开发了一种无需额外化学试剂即可固定EpCAM抗体的简单策略。通过利用光功能化二氧化钛(TiO)的正电荷特性,EpCAM抗体带负电荷的羧基末端通过静电相互作用被固定,使抗体能够充分暴露抗原结合位点。实验结果表明,光功能化TiO表面具有显著的正电荷和超亲水性,能够固定大量EpCAM抗体并保持优异活性。CTC捕获实验表明,EpCAM抗体修饰的光功能化TiO能够高效捕获CTC。兔血液循环实验结果表明,EpCAM抗体修饰的光功能化TiO能够从全身血液中准确捕获CTC。可以预见,基于光功能化TiO简单固定EpCAM抗体的策略有望在未来用于高效捕获CTC。